Pratite feedove: blogove, vesti, RSS i još mnogo toga. Jednostavan način da čitate i pratite sadržaj koji sami birate.
Preuzmite FeederRSS izvori za Farmacija koje korisnici aplikacije Feeder najviše prate, uključujući Mineralys Therapeutics, Inc. (MLYS) Press Releases, News i PTC Therapeutics, Inc. News Releases. Kopirajte URL izvora ili ih besplatno pratite u aplikaciji Feeder.
Zdravlje RSS feedovi Onkologija RSS feedovi Klinička ispitivanja RSS feedovi Medicinska istraživanja RSS feedovi Mentalno zdravlje RSS feedovi Psihologija RSS feedovi Javno zdravlje RSS feedovi
Predloži izmenuDailyMed provides high quality information about marketed drugs. Drug labeling on this Web site is the most recent submitted to the Food and Drug Administration (FDA) and currently in use; it may include strengthened warnings undergoing FDA review and minor editorial changes.
New contents from the website www.hma.eu. Category: Recently Published CMDh
Studies found on ClinicalTrials.gov by a search of: Other terms: NCT06087835 | Last update posted in the last 14 days
New drug approvals news from Drugs.com. Comprehensive, up-to-date drug news for consumers and healthcare professionals.
Leading the way in life science technologies
Headline news from Drugs.com. Comprehensive, up-to-date drug news for healthcare professionals.
Biotech news: Inside the discoveries, personalities, and deals driving drug development in general and biomedical engineering in particular. Sign up for <a href="https://www.statnews.com/signup/readout/">The Readout</a> newsletter to get the latest on biotech delivered to your inbox.
Die aktuellsten Meldungen aus Gesundheitspolitik und Medizin
Business Wire - The global leader in news distribution
Altroconsumo è un'associazione di consumatori, la prima e la più diffusa in Italia con i suoi 300.000 Soci. Indipendente e senza fini di lucro, ha un unico obiettivo: l'informazione e la tutela dei consumatori.
The latest news released by Cellectar Biosciences, Inc. (CLRB)
The latest news released by Medexus Pharmaceuticals, Inc. (MDP)
Developing the next generation of oncology therapies for patients.